Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Champions Oncology, Inc. (CSBR)

Biological Products, (no Disgnostic Substances)

https://www.championsoncology.com

Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.

855 N. WOLFE STREET, SUITE 619
BALTIMORE, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/02/2007

Market Cap

60,084,596

Shares Outstanding

13,590,000

Weighted SO

13,593,767

Total Employees

N/A

Upcoming Earnings

07/18/2024

Beta

0.4930

Last Div

0.0000

Range

4.42-7.13

Chg

-0.0800

Avg Vol

6709

Mkt Cap

60084596

Exch

NASDAQ

Country

US

Phone

201 808 8400

DCF Diff

9.1284

DCF

-4.5000

Div Yield

0.0000

P/S

1.1980

EV Multiple

-15.1947

P/FV

-31.5735

Div Yield %

0.0000

P/E

-8.2579

PEG

-0.6578

Payout

0.0000

Current Ratio

0.6332

Quick Ratio

0.6332

Cash Ratio

0.1215

DSO

69.3263

DIO

0.0000

Op Cycle

69.3263

DPO

72.0044

CCC

-2.6781

Gross Margin

0.4138

Op Margin

-0.1380

Pretax Margin

-0.1457

Net Margin

-0.1451

Eff Tax Rate

0.0044

ROA

-0.2784

ROE

14.8112

ROCE

-1.5073

NI/EBT

0.9956

EBT/EBIT

1.0561

EBIT/Rev

-0.1380

Debt Ratio

0.2843

D/E

-3.9044

LT Debt/Cap

1.4542

Total Debt/Cap

1.3443

Int Coverage

0.0000

CF/Debt

-0.8260

Equity Multi

-13.7320

Rec Turnover

5.2650

Pay Turnover

5.0691

Inv Turnover

999999.9999

FA Turnover

4.1889

Asset Turnover

1.9193

OCF/Share

-0.4515

FCF/Share

-0.5130

Cash/Share

0.1926

OCF/Sales

-0.1224

FCF/OCF

1.1362

CF Coverage

-0.8260

ST Coverage

-4.5901

CapEx Coverage

-7.3409

Div&CapEx Cov

-7.3409

P/BV

-31.5735

P/B

-31.5735

P/S

1.1980

P/E

-8.2579

P/FCF

-8.6167

P/OCF

-9.7905

P/CF

-9.7905

PEG

-0.6578

P/S

1.1980

EV Multiple

-15.1947

P/FV

-31.5735

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation